As was recently demonstrated, elevated expression of EGFR or phospho-EGFR, such as that observed in U87ΔEGFR glioma tumors, does not guarantee enhanced uptake of [11C]erlotinib [24]. Here, EGFR is linked to central nervous system cancer.